One possibility is that the upregulation of CDH1/E-cad expression in carcinoma cells is an adaptive response to the abnormal signaling inside tumor cells, which is known to result in increasingly altered cell–cell adhesion and actin cytoskeleton rearrangement during tumor formation, progression, and invasion [69–71]. The gene discussed is CDH1; the disease is neoplasm.